Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
End stage kidney disease
How would you counsel a patient with CKD Stage 5 and prediabetes who is concerned about their risk of developing diabetes if they start peritoneal dialysis?
Related Questions
When would you suspect an allergy to the dialysis membrane in patients who complain of pruritis during dialysis?
Do you take any special considerations for a patient with ESKD who has an ileostomy/colostomy and wishes to start peritoneal dialysis?
For patients on peritoneal dialysis with type 2 diabetes mellitus, do you have a preferred long- acting insulin and time of insulin administration?
What degree of prolactin elevation is typically seen in patients with end stage kidney disease on hemodialysis?
What is your approach to intensifying the hemodialysis prescription for patients found to have dialysis-related amyloidosis?
Are there instances when you would prescribe a phosphate binder to an ESKD patient on hemodialysis who has a phosphorus level in the target range of less than 5.5 mg/dL?
What is your approach to dosing sodium thiosulfate for a patient with ESKD who is receiving CRRT?
What is your approach for ESKD patients on peritoneal dialysis who request to do their own exchanges during a hospitalization?
How do you modify the hemoglobin goal and ESA dosing for patients with sickle cell anemia and ESKD on hemodialysis?
How would you manage an ESKD patient who complains of severe fatigue after hemodialysis, but does not experience intradialytic or post-dialysis hypotension and has not responded to dry weight adjustments?
